Status:
RECRUITING
Investigating the Clinical Utility of the Oxford Virtual Autism Assessment Tool (OVAAT)
Lead Sponsor:
Oxford Health NHS Foundation Trust
Conditions:
Autism Spectrum Disorder
Healthy
Eligibility:
All Genders
13-18 years
Phase:
NA
Brief Summary
The goal of the study is to evaluate a new Autism Spectrum Disorder (ASD) diagnostic tool (Oxford Virtual Autism Assessment Tool (OVAAT)) to see whether it can: * Be able to identify autistic traits ...
Detailed Description
Background and study aims: Standardised tools (i.e. tools that have been formally researched/evaluated) are a key part of ASD assessments. Some young people prefer online to face-to-face assessments....
Eligibility Criteria
Inclusion
- Group 1: 13-18 year old young people waiting for an autism assessment in the Oxfordshire CAMHS Neurodevelopmental Conditions (NDC) pathway who have access to and are able to use a laptop or desktop computer and a quiet place to complete the assessment.
- Group 2: 13-18 year old young people with no neurodevelopmental or mental health conditions who have access to and are able to use a laptop or desktop computer and a quiet place to complete the assessment.
Exclusion
- Group 1: 13-18 year old young people waiting for an autism assessment in the Oxfordshire CAMHS NDC pathway who have an existing or suspected neurodevelopmental diagnosis other than autism (e.g. ADHD, Learning Disability) or significant mental health problem (e.g. major depression, psychosis, eating disorder) and/or who are unable to speak English fluently.
- Group 2: 13-18 year olds with any suspected or current neurodevelopmental or mental health conditions and/or who are unable to speak English fluently.
Key Trial Info
Start Date :
September 22 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06582290
Start Date
September 22 2023
End Date
May 1 2025
Last Update
September 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oxford Health NHS Foundation Trust
Oxford, United Kingdom, OX3 7JH